Compare PLNT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLNT | BRKR |
|---|---|---|
| Founded | 1992 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.6B |
| IPO Year | 2015 | 2000 |
| Metric | PLNT | BRKR |
|---|---|---|
| Price | $73.83 | $34.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $116.67 | $49.54 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,324,144,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $19.22 | $6.27 |
| Revenue Next Year | $11.66 | $3.78 |
| P/E Ratio | $38.47 | ★ N/A |
| Revenue Growth | ★ 12.06 | N/A |
| 52 Week Low | $73.01 | $28.53 |
| 52 Week High | $114.47 | $56.22 |
| Indicator | PLNT | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 39.19 |
| Support Level | $73.01 | $29.54 |
| Resistance Level | $76.74 | $35.15 |
| Average True Range (ATR) | 2.55 | 1.69 |
| MACD | 0.48 | 0.27 |
| Stochastic Oscillator | 15.70 | 40.40 |
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.